Chemical formula: C₁₀H₁₇NO₅S Molecular mass: 263.31 g/mol
Etamsylate is a synthetic antihaemorrhagic and angioprotective drug acting on the first step of haemostasis (endothelium-platelet interaction). By improving platelet adhesiveness and restoring capillary resistance, it is able to reduce bleeding time and blood losses.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B02BX01 | Etamsylate | B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BX Other systemic hemostatics |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| DICYNONE 250 Solution for injection | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| DICYNONE 500 Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
Etamsylate is an active ingredient of these brands:
Cyprus (CY)Ecuador (EC)Estonia (EE)France (FR)Lithuania (LT)Mexico (MX)Poland (PL)Singapore (SG)Tunisia (TN)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
